Imminent shortage of drug used in acute stroke treatment: “Don’t lose a milliliter”

There is a threat of a shortage of the drug Actilyse, which is used for the acute treatment of a cerebral infarction. The only company in the world that markets the drug is struggling with supply problems. “Hospitals are being urged to handle their stock responsibly,” says Robin Lemmens, neurologist at UZ Gasthuisberg in Leuven and vice-chairman of the Belgian Stroke Council.